Actually, I have been taking them even now. One does not even need a scrip for that, they are OTC-available, and that cheaply. In Decemner I had a lingering upper respiratory infection, and (knowing nothing then of the virus pan-mania) I persuaded my physician to prescribe the azithromycin Z-pak course, which completely rid me of that infection in hours. Been well ever since.
In July, I had to have a molar extracted at the local hospital, for which they required a test for the virus. Result: no antibodies or indication of symptoms, though I have been out and about all during the masking era. And I am 83, daily doing carpentry and handyman work, climbing to the roof on ladders, painting, etc.
So, there; that's one anecdote supporting my opinion that should I get the virus, I would want the HCQ/Z-pak immediately. I don't know if my PhD in chemistry would help, but I would think so.
Woe to the attending physician that does not comply. There are malpractice lawyers to attend to that type of deficiency in treatment, even if by my progeny. Murder by virus is a charge that will be coming up soon, eh?
Hear this, you golden-agers like me!
Overall, 2,541 consecutive patients were included in the analyses with a median age of 64 years (IQR: 53–76 years), 51% male, 56% African American, median inpatient LOS was 6 days (IQR: 4–10 days). The median time to follow-up was 28.5 days (IQR 3–53). The majority of patients (52%, n = 1,250) had BMI ≥ 30. Additional underlying comorbidities are detailed in Table 1. On the day of admission, two variables predicting severity of disease and mortality, highest mSOFA score and lowest O2 saturation, were recorded. However, 25% of the population did not have mSOFA scores available, as recording of this metric became institutional standard one month after the index admission. Other indicators of severity were ICU admission and mechanical ventilation status. All baseline characteristics were further stratified by the four treatment groups (hydroxychloroquine alone, hydroxychloroquine + azithromycin, azithromycin alone, and neither treatment). Median time (IQR) from admission to receipt of hydroxychloroquine was 1 day (1–2). Overall crude mortality rates were 18.1% in the entire cohort, 13.5% in the hydroxychloroquine alone group, 20.1% among those receiving hydroxychloroquine + azithromycin, 22.4% among the azithromycin alone group, and 26.4% for neither drug (p < 0.001). Adjunct therapy with corticosteroids (methylprednisolone and/or prednisone) and anti-IL-6 tocilizumab was provided in 68% and 4.5% of patients, respectively.
The above was linked to from the original article posted:
I think I read that the AMA threatened to take away doctors licenses if they prescribed hydroxechloroquin. I also read that pharmacists are hesitant to prescribe it.
When the national propaganda machine all attacked hydroxe they warned that there were heart issues but you can see ads for pharmaceuticals all day long on television with all kinds of side effects and no one forbids them from being shown.